5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents

5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents 5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists Pyridine-2-propanoic acids: Discovery of dual PPARα/γ agonists as antidiabetic agents Pyridine-3-propanoic acids: Discovery of dual PPARα/γ agonists as antidiabetic agents Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents